Antibodies to BrkA augment killing of Bordetella pertussis

Vaccine

Volumn 20, Issue 1-2, 2001, Pages 235-241

  Oliver, David C ^a   Fernandez, Rachel C ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

B. pertussis; Recombinant BrkA; Serum resistance

Indexed keywords

HISTIDINE; HYBRID PROTEIN; NEUTRALIZING ANTIBODY; PERTACTIN; PERTUSSIS VACCINE; POLYCLONAL ANTIBODY; PROTEIN; PROTEIN BRKA; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BACTERICIDAL ACTIVITY; BORDETELLA PERTUSSIS; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GRAM NEGATIVE BACTERIUM; NONHUMAN; OUTER MEMBRANE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN SYNTHESIS; SERUM;

ADULT; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BLOOD BACTERICIDAL ACTIVITY; BORDETELLA PERTUSSIS; HUMANS; IMMUNE SERA; NEUTRALIZATION TESTS; PEPTIDE FRAGMENTS; PERTUSSIS VACCINE; PROTEIN PRECURSORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RABBITS; RECOMBINANT FUSION PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 0035850984     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00269-9     Document Type: Article

References (41)

1. Bordetella pertussis infection: Pathogenesis, diagnosis, management, and the role of protective immunity
2. Cloning and sequencing of a Bordetella pertussis serum resistance locus
3. Lethal infection by Bordetella pertussis mutants in the infant mouse model
4. Invasion of He-La cells by virulent Bordetella pertussis
5. Plasma exudation as a first line respiratory mucosal defence
6. Serum resistance in bvg-regulated mutants of Bordetella pertussis
7. Susceptibilities of Bordetella pertussis strains to anti-microbial peptides
8. Characterization of human bactericidal antibodies to Bordetella pertussis
9. Tn5-induced mutations affecting virulence factors of Bordetella pertussis
10. Use of the promotor fusion transposon Tn5 lac to identify mutations in Bordetella pertussis vir-regulated genes
11. The C-terminal domain of the Bordetella pertussis autotransporter BrkA forms a pore in lipid bilayer membranes
12. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
13. The great escape: Structure and function of the autotransporter proteins
14. The antigen of Bordetella pertussis that induces bactericidal antibody and its relationship to protection of mice
15. Bactericidal antibody in serum during infection with Bordetella pertussis
16. Characterization and comparative bactericidal activity of monoclonal antibodies to Bordetella pertussis lipo-oligosaccharide A
17. Variation of killing power of human sera against Bordetella pertussis
18. Biological activity of a human monoclonal antibody to Bordetella pertussis lipo-oligosaccharide
19. Characterization of the antibodies responsible for the bactericidal activity patterns of antisera to Bordetella pertussis
20. Taxonomic distribution of the antigen eliciting bactericidal antibody for Bordetella pertussis
21. Biochemical and immunological properties of two forms of pertactin, the 69 000-molecular-weight outer-membrane protein of Bordetella pertussis
22. Bordetella pertussis-specific Th1/Th2 cells generated following respiratory infection or immunization with an acellular vaccine: Comparison of the T-cell cytokine profiles in infants and mice
23. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis
24. A regulatory role for interleukin-4 in differential inflammatory responses in the lung following infection of mice primed with Th1- or Th2-inducing pertussis vaccines
25. A bactericidal monoclonal antibody specific for the lipo-oligosaccharide of Bordetella pertussis reduces colonization of the respiratory tract of mice after aerosol infection with B. pertussis
26. The seroepidemiology of Bordetella pertussis infections: A study of persons ages 1-65 years
27. Epidemiological, clinical, and laboratory aspects of pertussis in adults
28. Household contact study of Bordetella pertussis infections
29. Widespread silent transmission of pertussis in families: Antibody correlates of infection and symptomatology
30. Pertussis and its prevention: A family affair
31. Waning immunity and sub-clinical infection in an epidemic model: Implications for pertussis in NLD
32. Bordetella pertussis virulence factors affect phagocytosis by human neutrophils
33. Mucosal immune defenses and the response of Bordetella pertussis
34. Neutralizing antibodies to adenylate cyclase toxin promote phagocytosis of Bordetella pertussis by human neutrophils
35. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses
36. Serological correlates of immunity to Bordetella pertussis
37. The acellular pertussis vaccine trials: An interpretation
38. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis
39. Vaccine- and antigen-dependent types 1 and 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines
40. Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: Variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0
41. Characterization of bactericidal immune responses following vaccination with acellular pertussis vaccines in adults